Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on HanAll Biopharma Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 19 Sep 2023 | HanAll Biopharma Co Ltd Enters Phase I Clinical Trial Agreement with Syneos Health Inc for ATH-399A (GDCT0501023) | Contract Service Agreement |
HanAll Biopharma Co Ltd
|
Syneos Health Inc |
| 12 Jun 2023 | HanAll Biopharma and Daewoong Pharma Invests in Vincere Biosciences | Private Equity |
Daewoong Pharmaceutical Co Ltd
HanAll Biopharma Co Ltd |
Vincere Biosciences Inc
|
| 25 May 2023 | HanAll Biopharma and Daewoong Pharma Enter into Co-Development Agreement with NurrOn Pharma | Partnership | - |
NurrOn Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd HanAll Biopharma Co Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer